Crossmark

Is PI‑RADS upgrading the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI‑RADS‑3 lesions?

Published Online: 2024-04-03

Authors

Sanjari, Elaheh

Raeisi Shahraki, Hadi https://orcid.org/0000-0003-3071-5587
License Information

Text and Data Mining valid from 2024-04-03

Version of Record valid from 2024-04-03
More Information

Article History

Received: 15 March 2024

Accepted: 19 March 2024

First Online: 3 April 2024

Declarations

:

: Nothing.

Free to read: This content has been made available to all.

Document is current